martes, 23 de enero de 2018

Juluca Label Updated

U.S. Food and Drug Administration Header

The Juluca (dolutegravir/rilpivirine) label was updated to correct dosing separation information between Juluca and oral calcium and iron supplements as follows:
  •  Administer JULUCA and supplements containing calcium or iron together with a meal or take JULUCA 4 hours before or 6 hours after taking these supplements.
The updated label will soon be available at drugs@fda or DailyMed
Steve Morin
Office of Health and Constituent Affairs
Food and Drug Administration
Kimberly Struble
Division of Antiviral Products
Food and Drug Administration

No hay comentarios:

Publicar un comentario